Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hayward

Showing results (641-650 of 927) with videos related to

Pageof 93
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2018
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathyClaire Horvat, Renee Johnson, Lien Lam, et al.
Circulation. Genomic and Precision Medicine|September 6, 2023
DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and PhenocopiesRenee Johnson, Robyn Otway, Ephrem Chin, et al.
American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.
BMJ Neurology Open|September 26, 2025
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialKathryn S Hayward, Geoffrey Donnan, Erin Godecke, et al.
JACC. Heart Failure|June 10, 2026
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF IIShunichi Doi, Sho Kazui, Naoyuki Akashi, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Science Translational Medicine|January 16, 2015
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and diseaseAngharad M Roberts, James S Ware, Daniel S Herman, et al.
Journal of the American Heart Association|May 16, 2022
Chronic Stroke Sensorimotor Impairment Is Related to Smaller Hippocampal Volumes: An ENIGMA AnalysisArtemis Zavaliangos-Petropulu, Bethany Lo, Miranda R Donnelly, et al.
Human Brain Mapping|April 21, 2020
The ENIGMA Stroke Recovery Working Group: Big data neuroimaging to study brain-behavior relationships after strokeSook-Lei Liew, Artemis Zavaliangos-Petropulu, Neda Jahanshad, et al.
Pageof 93

Showing results (641-650 of 927) with videos related to

Sort By:
Pageof 93
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2018
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathyClaire Horvat, Renee Johnson, Lien Lam, et al.
Circulation. Genomic and Precision Medicine|September 6, 2023
DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and PhenocopiesRenee Johnson, Robyn Otway, Ephrem Chin, et al.
American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.
BMJ Neurology Open|September 26, 2025
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialKathryn S Hayward, Geoffrey Donnan, Erin Godecke, et al.
JACC. Heart Failure|June 10, 2026
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF IIShunichi Doi, Sho Kazui, Naoyuki Akashi, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Science Translational Medicine|January 16, 2015
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and diseaseAngharad M Roberts, James S Ware, Daniel S Herman, et al.
Journal of the American Heart Association|May 16, 2022
Chronic Stroke Sensorimotor Impairment Is Related to Smaller Hippocampal Volumes: An ENIGMA AnalysisArtemis Zavaliangos-Petropulu, Bethany Lo, Miranda R Donnelly, et al.
Human Brain Mapping|April 21, 2020
The ENIGMA Stroke Recovery Working Group: Big data neuroimaging to study brain-behavior relationships after strokeSook-Lei Liew, Artemis Zavaliangos-Petropulu, Neda Jahanshad, et al.
Pageof 93